ClearPoint Neuro (CLPT) Competitors

ClearPoint Neuro (NASDAQ:CLPT) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

Do analysts recommend CLPT or ESTA?

ClearPoint Neuro presently has a consensus price target of $25.00, suggesting a potential upside of 120.65%. Establishment Labs has a consensus price target of $54.83, suggesting a potential upside of 25.59%. Given ClearPoint Neuro's stronger consensus rating and higher possible upside, analysts plainly believe ClearPoint Neuro is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Establishment Labs	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Which has preferable earnings & valuation, CLPT or ESTA?

ClearPoint Neuro has higher earnings, but lower revenue than Establishment Labs. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$32.24M	9.84	-$18.91M	-$0.76	-14.91
Establishment Labs	$166.02M	7.61	-$84.60M	-$3.10	-14.08

Is CLPT or ESTA more profitable?

Establishment Labs has a net margin of -52.34% compared to ClearPoint Neuro's net margin of -64.51%. ClearPoint Neuro's return on equity of -78.09% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-64.51%	-78.09%	-51.33%
Establishment Labs	-52.34%	-196.25%	-26.64%

Do insiders & institutionals have more ownership in CLPT or ESTA?

30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 7.0% of ClearPoint Neuro shares are held by company insiders. Comparatively, 11.1% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the media refer more to CLPT or ESTA?

In the previous week, Establishment Labs had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 6 mentions for Establishment Labs and 4 mentions for ClearPoint Neuro. Establishment Labs' average media sentiment score of 1.16 beat ClearPoint Neuro's score of 0.38 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ClearPoint Neuro	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Establishment Labs	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, CLPT or ESTA?

ClearPoint Neuro has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500.

Summary

Establishment Labs beats ClearPoint Neuro on 9 of the 16 factors compared between the two stocks.